Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyaluronan synthase 2 is an enzyme encoded by the HAS2 gene in humans. It catalyzes the synthesis of hyaluronan (hyaluronic acid), a high molecular weight unbranched polysaccharide that is a major component of the extracellular matrix. The enzyme operates at the inner surface of the plasma membrane, extruding newly synthesized hyaluronan chains into the extracellular space. Hyaluronan plays critical roles in tissue architecture by providing structural support, facilitating cell migration during wound healing and tissue repair, lubricating joints, and serving as a scaffold for blood vessel growth and fibroblast ingrowth. Altered expression or activity of HAS2 has been linked to pathological conditions such as cancer metastasis—through its role in cell motility—and inflammatory diseases like rheumatoid arthritis due to changes in extracellular matrix composition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronan synthase 2 (HAS2).